Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Jon C. Ogg | Feb 22, 2017 at 11:25 AM EST

With New Cash and Cancer Targets, Analyst Sees Almost 200% Upside in Sierra Oncology

After a fresh capital raise of about $26 million, at least one analyst is calling for Sierra Oncology stock to…

Chris Lange | Feb 21, 2017 at 11:10 AM EST

Tuesday’s Top Biopharma Movers

A few biopharma companies have made massive runs on Tuesday morning.

Trey Thoelcke | Feb 20, 2017 at 7:35 AM EST

What Are the Odds That Your Medical Information Has Been Stolen?

A recent survey showed that one in four U.S. consumers have had their personal medical information stolen from technology systems,…

Chris Lange | Feb 16, 2017 at 12:05 PM EST

Why This FDA Approval for Valeant Is Not as Good as First Thought

Valeant Pharmaceuticals received a key FDA approval early on Thursday, but it seems to be a mixed blessing.

Chris Lange | Feb 16, 2017 at 9:30 AM EST

How Alexion’s Pipeline Is Driving Earnings

Alexion Pharmaceuticals released a mixed most recent earnings report before the markets opened on Thursday.

Jon C. Ogg | Feb 15, 2017 at 3:04 PM EST

How Gene Editing Just Got Rocked by Major Patent Ruling

The possibilities around gene editing are almost endless. Some of the goals and hopes around gene editing sound like they…

Paul Ausick | Feb 15, 2017 at 12:25 PM EST

Has the IRS Driven the First Nail Into Obamacare’s Coffin?

The IRS will not require taxpayers to prove they had medical insurance last year, threatening the very existence of the…

Chris Lange | Feb 15, 2017 at 12:10 PM EST

Merck Delivers Even More Disappointing News in Alzheimer’s Study

Merck saw its shares slip on Wednesday after the firm reported that it will be halting its mid-to-late-stage clinical trial…

Chris Lange | Feb 15, 2017 at 10:55 AM EST

Why Evoke Pharma Shares Are Exploding

Evoke Pharma saw its shares jump on Wednesday after the company issued an update that it received from the FDA.

Chris Lange | Feb 14, 2017 at 1:45 PM EST

What Analysts Are Saying About Teva Pharmaceutical After Earnings

After Teva Pharmaceutical International reported fourth-quarter and full-year 2016 on Monday, only a few analysts weighed in initially, but the…

Chris Lange | Feb 13, 2017 at 12:10 PM EST

Can Sage Therapeutics Press Even Further With Its Depression Trial?

Shares of Sage Therapeutics saw a handy gain on Monday after the company announced a successful mid-stage trial for the…

Chris Lange | Feb 13, 2017 at 11:10 AM EST

Can Zosano Pharma Turn Itself Around With This Late-Stage Migraine Trial Win?

Zosano Pharma saw its shares absolutely skyrocket on Monday after the firm gave an update on its late-stage trial for…

Paul Ausick | Feb 13, 2017 at 7:55 AM EST

How Rosy Is the Outlook for Teva Pharmaceutical?

Teva beat estimates on earnings and revenues for both the quarter and the fiscal year and its outlook for 2017…

Douglas A. McIntyre | Feb 11, 2017 at 8:35 AM EST

Americans, Worried About Heart Disease, Don’t Know What Causes It

Americans are worried about dying from heart disease. However, a new study shows that most people don't know what causes…

Chris Lange | Feb 10, 2017 at 9:55 AM EST

Major Biotechs Scare Off Loads of Short Sellers

As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears…

1 … 173 174 175 176 177 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

With New Cash and Cancer Targets, Analyst Sees Almost 200% Upside in Sierra Oncology

Tuesday’s Top Biopharma Movers

What Are the Odds That Your Medical Information Has Been Stolen?

Why This FDA Approval for Valeant Is Not as Good as First Thought

How Alexion’s Pipeline Is Driving Earnings

How Gene Editing Just Got Rocked by Major Patent Ruling

Has the IRS Driven the First Nail Into Obamacare’s Coffin?

Merck Delivers Even More Disappointing News in Alzheimer’s Study

Why Evoke Pharma Shares Are Exploding

What Analysts Are Saying About Teva Pharmaceutical After Earnings

Can Sage Therapeutics Press Even Further With Its Depression Trial?

Can Zosano Pharma Turn Itself Around With This Late-Stage Migraine Trial Win?

How Rosy Is the Outlook for Teva Pharmaceutical?

Americans, Worried About Heart Disease, Don’t Know What Causes It

Major Biotechs Scare Off Loads of Short Sellers

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

With New Cash and Cancer Targets, Analyst Sees Almost 200% Upside in Sierra Oncology

Tuesday’s Top Biopharma Movers

What Are the Odds That Your Medical Information Has Been Stolen?

Why This FDA Approval for Valeant Is Not as Good as First Thought

How Alexion’s Pipeline Is Driving Earnings

How Gene Editing Just Got Rocked by Major Patent Ruling

Has the IRS Driven the First Nail Into Obamacare’s Coffin?

Merck Delivers Even More Disappointing News in Alzheimer’s Study

Why Evoke Pharma Shares Are Exploding

What Analysts Are Saying About Teva Pharmaceutical After Earnings

Can Sage Therapeutics Press Even Further With Its Depression Trial?

Can Zosano Pharma Turn Itself Around With This Late-Stage Migraine Trial Win?

How Rosy Is the Outlook for Teva Pharmaceutical?

Americans, Worried About Heart Disease, Don’t Know What Causes It

Major Biotechs Scare Off Loads of Short Sellers

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check